Epoch Investment Partners Inc. Sells 14,921 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Epoch Investment Partners cut its stake in Mettler-Toledo International by 13.8% in the first quarter, selling 14,921 shares and leaving it with 93,270 shares valued at about $117.6 million.
• Mettler-Toledo reported better-than-expected quarterly results, posting EPS of $8.91 versus $8.70 expected and revenue of $947.1 million, up 7.2% from a year earlier.
• Analyst sentiment remains cautious overall: several firms trimmed price targets, and the stock currently carries a Hold consensus rating with an average price target of $1,408.55.

Epoch Investment Partners Inc. lowered its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 13.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 93,270 shares of the medical instruments supplier's stock after selling 14,921 shares during the quarter. Epoch Investment Partners Inc. owned 0.46% of Mettler-Toledo International worth $117,632,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of MTD. Geneos Wealth Management Inc. boosted its position in Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier's stock worth $78,000 after purchasing an additional 30 shares during the last quarter. Baird Financial Group Inc. boosted its holdings in shares of Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier's stock worth $1,582,000 after buying an additional 40 shares during the last quarter. Jump Financial LLC grew its position in Mettler-Toledo International by 44.6% during the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier's stock valued at $476,000 after buying an additional 125 shares during the period. Cerity Partners LLC increased its holdings in Mettler-Toledo International by 10.8% during the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier's stock worth $4,740,000 after buying an additional 392 shares during the last quarter. Finally, AXA S.A. raised its position in Mettler-Toledo International by 2.9% in the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier's stock worth $5,433,000 after acquiring an additional 131 shares during the period. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,328.82 on Friday. The company's 50 day simple moving average is $1,207.11 and its two-hundred day simple moving average is $1,279.07. Mettler-Toledo International, Inc. has a 1 year low of $1,023.05 and a 1 year high of $1,525.17. The stock has a market capitalization of $26.86 billion, a PE ratio of 31.16, a P/E/G ratio of 2.78 and a beta of 1.24.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The company had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. During the same quarter last year, the business posted $8.19 earnings per share. The firm's revenue was up 7.2% compared to the same quarter last year. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, research analysts anticipate that Mettler-Toledo International, Inc. will post 46.63 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on MTD shares. Wall Street Zen lowered shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Saturday, May 16th. Weiss Ratings lowered Mettler-Toledo International from a "hold (c)" rating to a "hold (c-)" rating in a research note on Tuesday. Morgan Stanley cut their price target on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 12th. Barclays lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 14th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a "neutral" rating for the company in a research note on Monday, May 11th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $1,408.55.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company's product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.